Chemical Structure (Xer00 0002 01)
Xermelo Tablet
Product Images NDC 70183-125
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Xermelo (NDC 70183-125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lexicon Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Xer00 0002 02)
This text provides information on improvement and deterioration in bowel movement frequency among patients taking placebo or Xermelo 250 mg three times daily. It includes data on cumulative proportion of patients and change in overall average bowel movement frequency from baseline.*
Principal Display Panel (ShellPak Label)
This text provides instructions for using a medication called XERMELO (telotristat ethyl) tablets in a daily dose pack containing 3 tablets. It includes directions for opening the pack and a reminder about keeping medications out of reach of children.*
Principal Display Panel (28 Day Case Label)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
